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CytotoxicityAbstract Acanthopanax sessiliﬂorus, a small woody shrub has traditionally been referred to have
anticancer activity, but it has not been scientiﬁcally explored so far. Therefore, to investigate the
anticancer effects of A. sessiliﬂorus stem bark extracts (ASSBE), MDA-MB-231 and MCF-7 human
breast cancer cells were treated with one of its bioactive fractions, n-hexane (ASSBE-nHF).
Cytotoxicity (24 h) was determined by MTT assay and antiproliferative effect was assessed by
counting cell numbers after 72 h treatment using hemocytometer. The role of ASSBE-nHF on
apoptosis was analysed by annexin V-FITC/PI, Hoechst 33342 staining, DNA fragmentation pat-
tern and immunoblotting of apoptosis markers. For the assay of enhanced production of ROS and
mitochondrial membrane depolarization, speciﬁc stains such as DCFH-DA and JC-1 were used,
respectively. To understand the mode of action of ASSBE-nHF on MCF-7 cells, cells were pre-
treated with antioxidant, n-acetylcysteine. The hexane fraction of ASSBE showed maximum activ-
ity towards human breast cancer cells compared to other two fractions at a minimal concentration
of 50 lg/ml. The annexin V-FITC/PI, Hoechst 33342 staining, DNA fragmentation and
immunoblotting assays showed that ASSBE-nHF induces non-apoptotic cell death in MCF-7
and MDA-MB-231 cells. ASSBE-nHF signiﬁcantly increased the production of ROS and decreased
the mitochondrial membrane potential (MMP) in MCF-7 cells. Similarly, it decreased the MMP in
MDA-MB-231 cells, but had no effect on ROS production. Further, the cytotoxic effect of
The cytotoxic nature of Acanthopanax sessiliﬂorus stem bark extracts in human breast cancer cells 753ASSBE-nHF in MCF-7 cells was not signiﬁcantly reversed even in the presence of n-acetylcysteine,
an antioxidant. These ﬁndings revealed that ASSBE-nHF induces non-apoptotic cell death via
mitochondria associated with both ROS dependent and independent pathways in human breast
cancer cells.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf of King SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
For many decades, plants have not only been used as dietary
supplements but also as traditional medicines for various dis-
eases worldwide. This clearly shows the potential of plants as
a rich source of bioactive compounds. Acanthopanax sessil-
iﬂorus, belonging to the Araliaceae family, is a smaller woody
deciduous shrub widely distributed in Asian countries like
Korea, China, and Japan, has been used as traditional medici-
nes for various ailments, including cancer. Recently, the
extracts and compounds from various parts of this plant have
been reported to possess promising antimetastatic effect against
breast cancer cells, immunomodulatory, anti-inﬂammatory,
proapoptotic activity against colon cancer cells and antiplatelet
aggregation properties (Lee et al., 2012a,b, 2013; Kim et al.,
2013). However, the anticancer effects of this plant extracts
against human breast cancer cells have not yet been studied.
Breast cancer is a serious public health concern being the
second most common of all cancers and by far the most fre-
quent death reason of cancer amongst women throughout the
world (Ferlay et al., 2015). Although chemotherapies have been
found to effectively control the progression of breast cancer,
the adverse effects and the development of resistance to anti-
cancer drugs are a common clinical problem in the treatment
of various cancers including breast cancer (Brouckaert et al.,
2012). Therefore, identiﬁcation of effective chemotherapy for
breast cancer is highly desirable. According to the American
Cancer Society, breast cancer is classiﬁed into two types based
on the presence or absence of hormone receptors. MCF-7 cells
express receptors for the ovarian hormones, oestrogen and pro-
gesterone, whereas MDA-MB-231 cells lack the expression of
these hormone receptors. However, hormone receptor positive
breast cancer cells can generally be targeted by receptor antag-
onists, the occasional loss of receptors due to genetic lesions in
tumour cells needs an alternate treatment strategy. Hence, these
two different cell types provide an ideal in vitromodel system to
identify the potential anticancer drugs. Since, breast cancer has
become the most diagnosed cancer amongst Korean women
and generally worldwide (Jung et al., 2014), the present
study was aimed to investigate the cytotoxic potential of
A. sessiliﬂorus stem bark extracts (ASSBE) against MCF-7
and MDA-MB-231 human breast cancer cell lines.2. Materials and methods
2.1. Plant source
A. sessiliﬂorus stem bark (ASSB) was collected from
Hongcheon-gun, a local city in the Republic of Korea. The
plant was identiﬁed and authenticated in Kookmin
University, College of Forest Science by the corresponding
author Prof. Young-Kyoon Kim. A voucher specimen(YKAS-013) was deposited in the herbarium of the College
of Forest Science, Kookmin University, Korea.
2.2. Extraction and fractionation
Fresh ASSB was washed with water, cut into small pieces, air
dried at room temperature and powdered. About 1.5 kg of
powdered material was subjected to extraction with analytical
grade solvent, methanol (30 L) at 50 C, three times for 5 h
each. The crude extracts were ﬁltered through ﬁlter paper
and then concentrated under reduced pressure using rotary
evaporator. Further, the crude extracts (107.01 g) were sus-
pended in distilled water (1 L) and partitioned with n-hexane
(1 L) and then the remaining was partitioned with butane
(1 L). These two partitions and the remaining portion in
distilled water were concentrated under reduced pressure
(n-hexane, 23.6 g; butanol, 24.56 g; water, 52.82 g) and stored
at 20 C until further use.
2.3. Cell culture
The human breast cancer cell lines MDA-MB-231 and MCF-7
were obtained from the Korean Cell Line Bank, Korea. Cells
were grown in DMEM supplemented with 10% FBS and
antibiotics under 5% CO2 at 37 C. Cells were seeded at the
density of 2.5 · 104 to 1 · 105 per millilitre for the designed
experimental assays.
2.4. Cytotoxicity assay
The cytotoxic effect of fractions of ASSBE against human
breast cancer cells was determined according to the method
of Mosmann, with slight modiﬁcations (Mosmann, 1983).
Brieﬂy, cells were seeded into 96-well plates at the density of
5 · 103 cells/well. After 24 h of culture, the medium was
removed and replaced with a fresh medium containing
DMSO (vehicle control) or various concentrations (25, 50,
100, 250 and 500 lg/ml) of n-hexane, butanol and aqueous
fractions of ASSBE. Following 24 h incubation, the media
was discarded, cells were washed with PBS once and 100 ll
of MTT solution (0.5 mg/ml in serum and phenol red free
DMEM) was added to each well, incubated for 4 h at 37 C.
Afterwards, the solution was discarded and 100 ll of DMSO
was added to each well and absorbance was measured at
570 nm. Three independent experiments were carried out for
each fraction. The results were expressed as the percentage
of viable cells in comparison with the control cells.
2.5. Anti-proliferative assay
Cells were seeded into 35 mm dish at the density of 2.5 · 104
cells/ml and incubated overnight. Subsequently, the cells were
754 V. Thamizhiniyan et al.treated with ASSB-nHF (25, 50 and 100 lg/ml) in complete
growth medium for 72 h. Afterwards, cells were washed with
PBS, harvested and cell numbers were counted by Trypan blue
dye exclusion using hemocytometer.
2.6. Morphological assessment
Cells were seeded into 60 mm dish at the density of 1 · 105
cells/ml and allowed to adhere overnight. After 24 h treatment
with ASSB-nHF (25, 50 and 100 lg/ml), the morphological
characteristics were observed and the images were captured
under an inverted phase-contrast microscope.
2.7. Determination of necrosis/apoptosis by annexin V/PI
staining
Apoptosis/necrosis was analysed using annexin V-FITC and
propidium iodide (PI) stain according to the manufacturer’s
instructions. Following 24 h treatment with ASSB-nHF (25,
50 and 100 lg/ml), the ﬂoating cells were collected and the
adherent cells were detached with accutase and centrifuged
at 100g. The pellets were pooled, washed with PBS, and resus-
pended in 1· binding buffer (1 · 106 cells/ml). 100 ll of cell
suspension was incubated with 5 ll of annexin V-FITC and
5 ll of PI for 15 min in the dark at room temperature. Then,
400 ll of 1· binding buffer was added and the samples were
analysed immediately by a ﬂow cytometer. For each sample,
10,000 events were collected and the results were analysed by
using BD accuri C6 software.
2.8. Nuclear staining with Hoechst 33342
Following 12 h treatment with ASSB-nHF (25, 50 and
100 lg/ml), cells were ﬁxed with 4% paraformaldehyde,Figure 1 Cytotoxic effects of different fractions of Acanthopanax sess
Cells were treated with n-hexane, butanol and aqueous fractions (25,
control for 24 h. Then, the cell viability was determined by the colori
corresponding control. Results are represented as the mean ± SD from
cells.stained with 5 lg/ml of Hoechst 33342 for 20 min at 37 C.
Then cells were washed with PBS, ﬂuorescent nuclei were
screened for normal, necrotic and apoptotic characteristics
using the Ti eclipse ﬂuorescence microscope.
2.9. Visualization of mitochondrial membrane potential (MMP)
Cells were treated with ASSB-nHF (25, 50 and 100 lg/ml) for
12 h, following this cells were incubated with 1 lg/ml of JC-1
in fresh medium for 30 min. Subsequently, cells were washed
with PBS twice, MMP was visualized by detecting ﬂuorescence
and images were captured at the Ti eclipse ﬂuorescence
microscope.
2.10. Detection of intracellular reactive oxygen species
The intracellular ROS level was determined based on the con-
version of non-ﬂuorescent substance, DCFH-DA into a highly
ﬂuorescent product DCF, as described previously. Brieﬂy, cells
were seeded into 35 mm dish at a density of 1 · 105 cells/ml
and incubated overnight. Following 12 h treatment with
ASSB-nHF (25, 50 and 100 lg/ml), the cells were incubated
with DCFH-DA (20 lM) for 30 min. After the removal of
excessive DCFH-DA, the cells were washed with PBS and
images were captured under ﬂuorescence microscope.
2.11. DNA fragmentation assay
Cells were treated with ASSB-nHF for 24 h and DNA frag-
mentation analysis was carried out according to the method
of Kasibhatla et al. (2006). Brieﬂy, 5 · 105 cells were trans-
ferred to sterile eppendorf tubes and lysed with 20 ll TES
(Tris, EDTA, SDS) lysis buffer by stirring with a wide-bore
pipette tip. Lysates were mixed with RNase A and RNaseiliﬂorus stem bark extracts (ASSBE) on human breast cancer cells.
50, 100, 250 and 500 lg/ml) or with 0.5% DMSO as the vehicle
metric MTT assay. The results are expressed as percentage of the
three independent experiments. *Signiﬁcant compared to control
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tion with proteinase K (10 ll) for 90 min at 50 C. Then 5 ll of
6· DNA loading buffer was added and electrophoresed on
1.5% agarose gel in TAE buffer at 50 V until loading dye
has reached two-third of the way down the gel. DNA ladders
were visualized by a UV light source after staining with ethid-
ium bromide and documented by photography.
2.12. Automated western analysis
Cells were lysed in RIPA buffer (50 mM Tris–HCl pH 8.0,
150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
SDS and supplemented with complete mini protease inhibitor
(Roche Life Science) and clariﬁed by centrifugation. Protein
concentration was determined using BCA kit (SigmaFigure 3 Effect of Acanthopanax sessiliﬂorus stem bark extracts on
characteristics were observed after 24 h treatment with ASSBE-nHF
microscope (200· magniﬁcation).
Figure 2 Anti-proliferative effect of Acanthopanax sessiliﬂorus stem
with ASSBE-nHF in complete growth medium for 72 h and then cells
exclusion method using a hemocytometer. Results are represented as
compared to control cells.Aldrich). Samples were adjusted to equal protein concentra-
tion with lysis buffer and western analysis was performed
according to the ProteinSimple (San Jose, California, 95134
USA) user manual. In brief, 4 parts of cell lysates (equal
amount of protein) were mixed with 1 part of master mix
(ProteinSimple) containing ﬂuorescent molecular weight mark-
ers and DTT (40 mM) and then heated at 95 C for 5 min. The
samples, biotinylated ladder and its respective secondary con-
jugate (ProteinSimple), blocking reagent, primary antibodies
(Caspase 8 from Novusbio, NB100-56116, 1:500 dilution;
Caspase 9 from CST, 9502, 1:100 dilution; Caspase 7 from
CST, 9492, 1:50 dilution; Caspase 3 from CST, 9662, 1:50 dilu-
tion; GAPDH from Santa cruz, sc-25778, 1:300 dilution),
HRP-conjugated secondary antibody (ProteinSimple), chemi-
luminescent substrate, and wash buffer were loaded into thethe morphology of human breast cancer cells. The morphological
and the images were captured under an inverted phase-contrast
bark extracts against human breast cancer cells. Cells were treated
were harvested and cell numbers were counted by trypan blue dye
the mean ± SD from three independent experiments. *Signiﬁcant
756 V. Thamizhiniyan et al.preﬁlled microplates containing separation and stacking matri-
ces. After plate loading, the separation electrophoresis and
immunodetection steps took place in the capillary system
and were fully automated (Chen et al., 2013).Figure 4 Necrosis like effect of Acanthopanax sessiliﬂorus stem bark
with ASSBE-nHF, both ﬂoating and adherent cells were harvested, s
percentage of necrotic and apoptotic cells in each group was analy
showing percentage distribution of viable (Q1), early apoptotic (Q4), la
treated groups.
Figure 5 Effect of Acanthopanax sessiliﬂorus stem bark extracts on
treated with ASSBE-nHF for 12 h. To assess the nuclear morphology
33342, and then the images were captured using ﬂuorescence micros
nucleus.2.13. Statistical analysis
Data are presented as the mean ± SD of six values in each
group. Data were analysed using SPSS 16.0 student softwareextracts on human breast cancer cells. Following 24 h treatment
tained with annexin V-FITC and propidium iodide and then the
sed by ﬂow cytometry. The representative ﬂuorescent histogram
te apoptotic (Q3) and dead (Q2) cells in control and ASSBE-nHF
the nuclear morphology of human breast cancer cells. Cells were
, cells were ﬁxed with 4% formaldehyde and stained with Hoechst
copy (400· magniﬁcation). The arrows red point to the necrotic
The cytotoxic nature of Acanthopanax sessiliﬂorus stem bark extracts in human breast cancer cells 757(SPSS Inc, Chicago, IL). The hypothesis-testing method
included one-way analysis of variance (ANOVA) followed by
post hoc testing with a least signiﬁcance difference test.
P< 0.05 was considered signiﬁcant.Figure 6 Effect of Acanthopanax sessiliﬂorus stem bark extracts
on DNA fragmentation in human breast cancer cells. Lane 1:
100 bp Ladder, Lane 2–4 treated MCF-7 cells with ASSBE-nHF
(0, 50, 100 lg/ml) for 24 h, Lane 5–7 treated MDA-MB-231 cells
with ASSBE-nHF (0, 50, 100 lg/ml) for 24 h. ASSBE-nHF
treatment didn’t induce apoptotic DNA fragmentation in both
the breast cancer cells.
Figure 7 Effect ofAcanthopanax sessiliﬂorus stembark extracts on
the levels of apoptosis markers in human breast cancer cells.
Representative western blotting data show the effect of ASSBE-
nHF on the levels of caspases and GAPDH proteins in MCF-7 and
MDA-MB-231 cells. The cells were treated with ASSBE-nHF
(100 lg/ml) for 0, 12 and24 h, and then immunoblotting for caspases
was performed using speciﬁc antibodies (Novusbio and Cell
Signalling Technology) in automated WES Proteinsimple instru-
ment with GAPDH (Santa cruz, sc-25778) as a loading control.3. Results and discussion
In search for new drug from traditional medicinal plants for
breast cancer, we investigated the effects of three different frac-
tions from methanolic extracts of A. sessiliﬂorus stem bark
using human breast cancer cell lines, MCF-7 and MDA-MB-
231. Treatment of cells with fractions at various concentrations
inhibited cell viability in dose dependent manner. Compared to
other two fractions, the hexane fraction (ASSBE-nHF) showed
greater cytotoxic effect towards both the MCF-7 (54.69% cell
death) and MDA-MB-231 (53.78% cell death) breast cancer
cell lines at a minimum concentration of 50 lg/ml (Fig. 1).
The IC50 values of the active fraction, ASSBE-nHF were
53.46 lg/ml for MDA-MB-231 cells and 58.40 lg/ml for
MCF-7 cells. Further, ASSBE-nHF signiﬁcantly suppressed
the proliferation of MCF-7 as well as MDA-MB-231 cells
(Fig. 2). In order to assess whether ASSBE-nHF induce any
morphological changes, cells were treated for 24 h and then
observed under a microscope. As shown in Fig. 3 ASSBE-
nHF treatment changed the cellular morphology. To elucidate
the ASSBE-nHF induced mode of action on breast cancer cells,
further experimental assays were performed.
More often cell death occurs by two alternate modes,
necrosis or apoptosis. Necrosis is characterized as passive,
accidental form of cell death resulting from environmental per-
turbations with uncontrolled release of inﬂammatory cellular
contents. Whereas, Apoptosis is a programmed, managed
form of cell death, occurs without eliciting local inﬂammatory
response. Apoptosis is an important physiological process for
the maintenance of tissue homeostasis and plays a pivotal role
in the pathogenesis of various disorders (Agostini et al., 2011).
In some pathological conditions, the crisis is due to abnormal
apoptosis, while in others, defective apoptosis is the cause.
Cancer is one of the scenarios where, defective apoptosis is also
a major causative factor, in addition to uncontrolled prolifer-
ation, resulting in tumour cells that will not die (Hipfner and
Cohen, 2004). Therefore, the unrestrained growth of malig-
nant cells and deregulation of apoptosis has become the major
targets for anticancer strategies (Sun et al., 2004; Chan et al.,
2012). Nevertheless, ASSBE-nHF induces cell death, to dis-
criminate whether it induces apoptosis in breast cancer cells,
the appearance of the early apoptosis biomarker phos-
phatidylserine at the cell surface was analysed by ﬂow cytom-
etry using annexin V-FITC and propidium iodide. It was
observed that ASSBE-nHF induces non-apoptotic cell death
in both MCF-7 and MDA-MB-231 breast cancer cells
(Fig. 4). This was also conﬁrmed by observing the nuclear
characteristics using Hoechst 33342 ﬂuorescence stain
(Fig. 5), absence of apoptotic DNA fragments and cleaved
fragments of caspases (Figs. 6 and 7).
In addition to its metabolic functions, mitochondria play a
major role in the management of other cellular functions like
cell survival and death (Galluzzi et al., 2012). Intriguingly,
mitochondria have several components that function as cell
death regulators. Following intrinsic or extrinsic excessive
stress beyond the recovery state associated with mitochondrialmembrane depolarization, cells die either via apoptosis or
other modes of cell death like necrosis (Zong and
Thompson, 2006; Parlato et al., 2014). Hence, to assess the
involvement of mitochondria in ASSBE-nHF induced cell
death, the mitochondrial membrane potential (MMP) was
studied using a cationic ﬂuorescent probe JC-1. It can selec-
tively enter into the mitochondrion of cells, and reversibly
Figure 8 Effect of Acanthopanax sessiliﬂorus stem bark extracts on mitochondrial membrane potential in human breast cancer cells.
Cells were treated with ASSBE-nHF for 12 h and then, cells were stained with a ﬂuorescent dye JC-1 for 30 min, washed with PBS,
visualized under ﬂuorescence microscopy and images were captured at 100· magniﬁcation.
Figure 9 Effect of Acanthopanax sessiliﬂorus stem bark extracts on the generation of ROS in breast cancer cells. After treatment with
ASSBE-nHF for 12 h, cells were incubated with DCFH-DA for 30 min and after the removal of excessive DCFH-DA, the cells were
washed twice with PBS and images were captured under ﬂuorescence microscope (100· magniﬁcation).
758 V. Thamizhiniyan et al.change from red to green ﬂuorescence as the mitochondrial
membrane potential decreases. By measuring such a shift in
the ﬂuorescence emission by ﬂuorescence microscopy, MMP
was readily detected. As shown in Fig. 8 ASSBE-nHF dose
dependently increased the ratio of green ﬂuorescence in both
cell lines which evidences the ASSBE-nHF induces cell
death in human breast cancer cells with the involvement of
mitochondrial membrane depolarization.Reactive oxygen species (ROS) are known to play dual role
either that may be beneﬁcial or harmful depending on their
accumulation levels. Apart from its importance in physiologi-
cal functions, ROS generally contributes to cell death either by
apoptosis or necrosis at the levels beyond the cellular antioxi-
dant defence mechanisms (Fiers et al., 1999; Mate´s and
Sa´nchez-Jime´nez, 2000). So, we determined the intracellular
ROS levels by measuring the intensity of a highly ﬂuorescent
Figure 10 Effect of n-acetylcysteine, an antioxidant on the
cytotoxicity of Acanthopanax sessiliﬂorus stem bark extracts in the
human breast cancer cells. MCF-7 cells were pre-treated with or
without n-acetylcysteine (2 mM) for 1 h and then n-hexane
fraction (50 and 100 lg/ml) for 24 h. Afterwards, the cell viability
was determined by the colorimetric MTT assay. The results are
expressed as percentage of the corresponding control. Results are
represented as the mean ± SD from three independent experi-
ments. *Signiﬁcant compared to control cells.
The cytotoxic nature of Acanthopanax sessiliﬂorus stem bark extracts in human breast cancer cells 759derivative 20,70-dichloroﬂuorescein (DCF) which is produced
from externally applied non-ﬂuorescent substance, DCFH-
DA by the cellular redox reactions. As shown in Fig. 9,
ASSBE-nHF dose dependently increased the ratio of green ﬂu-
orescence in MCF-7 cells suggesting that ASSBE-nHF stimu-
lates production of intracellular ROS in MCF-7 cells. On the
other hand it had no effect on ROS production in MDA-
MB-231 breast cancer cells. The antioxidant, n-acetylcysteine
(NAC) failed to reverse the cytotoxic effect of ASSBE-nHF
in MCF-7 cells (Fig. 10). This indicates that ASSBE-nHF
treatment led to ROS dependent and independent cell death
in human breast cancer cells.
4. Conclusion
In the present study, we were provided evidence that the hex-
ane fraction, a part of A. sessiliﬂorus stem bark methanolic
extracts induces cell death like necrosis in MCF-7 and
MDA-MB-231, human breast cancer cells. However, the result
of immunoblotting assay showed that ASSBE-nHF signiﬁ-
cantly reduced the levels of caspases including the housekeep-
ing protein GAPDH (Fig. 7). Since necrotic dying cells retain
the process of protein synthesis, A. sessiliﬂorus stem bark
extracts induced cell death in human breast cancer cells needs
further investigation (Saelens et al., 2005).
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